ClinicalTrials.govpublic full text
Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.
uveal melanoma with liver metastases, melanoma, uveal, liver metastases, immune checkpoint inhibitors, targeted therapies, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979394
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.